Backlog Boom Pushes Stifel to Upgrade Intuitive Machines to Buy
Backlog hits $1.76B (4.5x book-to-bill), implying ~48% upside despite Q2 miss.
Already have an account? Sign in.
Backlog hits $1.76B (4.5x book-to-bill), implying ~48% upside despite Q2 miss.
FDA review papers reveal encouraging Week 52 eGFR findings (+5.2 placebo-adjusted) for TRUTAKNA in primary IgA nephropathy patients.
Key reason: rapid shift to >90% AI revenue and exclusive position in high-power reliability testing for advanced chips.
US drone shares jumped in premarket as Trump imposed tariffs on foreign drones and parts to cut reliance on imports and strengthen national security.